OREANDA-NEWS. The vaccine "KoviVac", developed by the Chumakov Center of the Russian Academy of Sciences, has ended in Moscow, the registration for vaccination with this drug has been suspended, according to the website of the mayor and the government of Moscow.

"Currently, the vaccine" KoviVac "has ended. Registration for vaccination with this drug has been suspended. The Ministry of Health of Russia is expected to supply the next batch of vaccine," the message says.

Vaccination against coronavirus is carried out in all regions of the Russian Federation. In August 2020, the Ministry of Health of Russia registered the world's first vaccine for the prevention of COVID-19, developed by the Gamaleya Research Center for Electrochemistry. It was named "Sputnik V". Also in Russia, vaccines against COVID-19 have been created - "EpiVacCorona" from the "Vector" center of Rospotrebnadzor and "KoviVak", developed by the Chumakov Center of the Russian Academy of Sciences. In early May, it became known about the registration of the fourth domestic vaccine "Sputnik Light".

On June 16, the head of Rospotrebnadzor in Moscow, Elena Andreeva, decided to provide vaccination against coronavirus for workers in trade, services, catering, transport, health care, housing and communal services, MFC, education, culture and organizations working with children. According to the decree, at least 60% of employees must be vaccinated with two components of the vaccine in such organizations by mid-August. The Moscow region made a similar decision.

In addition, Moscow Mayor Sergei Sobyanin extended the restrictions imposed on the work of zoos, food courts, restrictions on night work of restaurants and the use of infrastructure in parks in the capital until June 29 inclusive, imposed due to coronavirus, the corresponding decree of the mayor was published on his official website. Also, a restriction on entertainment events is being introduced in the capital - a maximum of one thousand people can be present.